Normal view MARC view ISBD view

The effectiveness of community action in reducing risky alcohol consumption and harm: a cluster randomised controlled trial. [electronic resource]

By:

Shakeshaft, Anthony

Contributor(s):

Producer: 20141103Description: e1001617 p. digitalISSN:

1549-1676

Subject(s):

Online resources:

Available from publisher's website

In: PLoS medicine vol. 11

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1181 Hormonal factors.
1182 [Diamond-Blackfan anemia. Case report].
by Salariu, Magdalena
1183 [Effectiveness of hormonal therapy in hypoplastic (aplastic) anemia].
by Romanova, A F
1184 Clinical use of androgenic steroids at a major medical center: who prescribes androgens and how well do they do it?
by Cavanah, S F
1185 Liver Injury Associated with Sporting Activities.
by Hassan, Ammar
1186 Oestrogens and progestins in relation to human cancer.
1187 Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
by Kjaer, Thomas Nordstrøm
1188 The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels.
by Rosse, W F
1189 Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy.
by Flöter, A
1190 Implementation and Performance of the Gas Chromatography/Combustion/Isotope Ratio Mass Spectrometry-Based Method for the Confirmatory Analysis of Endogenous Anabolic Steroids during the Rio de Janeiro Olympic and Paralympic Games 2016.
by de Oliveira, Fábio Azamor
1191 Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells.
by Krongrad, A
1192 Influence of prostatic secretion protein on uptake of androgen-receptor complex in prostatic cell nuclei.
by Pousette, A
1193 Nonsteroidal progestins and antiprogestins related to flutamide.
by Dukes, M
1194 Anabolic-androgenic steroid abuse and psychopathology.
by Porcerelli, J H
1195 [Regulation of expression of pituitary tumor transforming gene 1 (PTTG1) by androgen in prostate cancer].
by Xin, Dian-qi
1196 Photoaffinity labeling identification of thyroid hormone-regulated glucocorticoid-binding peptides in rat liver endoplasmic reticulum: an oligomeric protein with high affinity for 16beta-hydroxylated stanozolol.
by Betancor-Hernández, Eva
1197 Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
by Ågren, Ulla M
1198 The developmental expression profile of PAX2 in the murine prostate.
by Chen, Qian
1199 Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
by Razavi, Zahra
1200 Importance of reversed-phase chromatographic parameters in predicting biopharmaceutical and pharmacokinetic descriptors on the group of androgen derivatives.
by Pilipović, Ana